Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2022
A common vesicle proteome drives fungal biofilm developmentRobert Zarnowski, Hiram Sanchez, Anna Jaromin, et al.
Open Forum Infectious Diseases|May 22, 2026
16S rRNA Bacterial Identification in Evaluation of Orthopedic Infections and its Limited Role in Antimicrobial StewardshipJoseph A McBride, Memee Moua, Alana Sterkel, et al.
Plos Pathogens|September 21, 2011
Hsp90 governs dispersion and drug resistance of fungal biofilmsNicole Robbins, Priya Uppuluri, Jeniel Nett, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activityWarren E Rose, Lucas T Schulz, David Andes, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosisBrad Spellberg, David Andes, Mario Perez, et al.
Drug Discovery Today|October 22, 2020
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistanceKushal Vanamala, Katyayani Tatiparti, Ketki Bhise, et al.
Eukaryotic Cell|September 10, 2005
LaeA, a regulator of morphogenetic fungal virulence factorsJin Woo Bok, S Arunmozhi Balajee, Kieren A Marr, et al.
The Journal of Antimicrobial Chemotherapy|November 14, 2024
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometricsDavid Andes, Roger J Brüggemann, Shawn Flanagan, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2009
Voriconazole use for endemic fungal infectionsAlison Freifeld, Laurie Proia, David Andes, et al.
Pageof 10